ESMO Breast Cancer 2023 Congress Coverage


 

ESMO Breast Cancer 2023 DORA Phase 2 Study: Durvalumab and Olaparib in Platinum-Treated Advanced TNBC

51 views
May 24, 2023
Comments 0
Login to view comments. Click here to Login